384 related articles for article (PubMed ID: 26928658)
1. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs.
Becskei C; De Bock F; Illambas J; Cherni JA; Fourie JJ; Lane M; Mahabir SP; Six RH
Vet Parasitol; 2016 May; 222():56-61. PubMed ID: 26928658
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of a chewable tablet containing sarolaner, moxidectin, and pyrantel (Simparica Trio
Becskei C; Liebenberg J; Fernandes T; Borowski S; D'Hanis L; Mahabir SP
Parasit Vectors; 2023 Nov; 16(1):441. PubMed ID: 38012719
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™) in the treatment of naturally occurring flea and tick infestations in dogs presented as veterinary patients in Europe.
Becskei C; De Bock F; Illambas J; Mahabir SP; Farkas R; Six RH
Vet Parasitol; 2016 May; 222():49-55. PubMed ID: 26994516
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of sarolaner, a novel oral isoxazoline, against two common mite infestations in dogs: Demodex spp. and Otodectes cynotis.
Six RH; Becskei C; Mazaleski MM; Fourie JJ; Mahabir SP; Myers MR; Slootmans N
Vet Parasitol; 2016 May; 222():62-6. PubMed ID: 26971196
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of orally and topically administered fluralaner (Bravecto
Chiummo R; Petersen I; Plehn C; Zschiesche E; Roepke R; Thomas E
Parasit Vectors; 2020 Oct; 13(1):524. PubMed ID: 33069261
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effectiveness of a novel oral formulation of sarolaner (Simparica™) for the treatment and control of fleas on dogs.
Six RH; Geurden T; Packianathan R; Colgan S; Everett WR; Grace S; Hodge A; Mahabir SP; Myers MR; Slootmans N; Davis K
Vet Parasitol; 2016 May; 222():18-22. PubMed ID: 26935820
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs.
Taenzler J; Liebenberg J; Roepke RK; Frénais R; Heckeroth AR
Parasit Vectors; 2016 Jul; 9(1):392. PubMed ID: 27387742
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of sarolaner against generalized demodicosis in dogs in European countries: a non-inferiority study.
Becskei C; Cuppens O; Mahabir SP
Vet Dermatol; 2018 Jun; 29(3):203-e72. PubMed ID: 29423956
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of sarolaner (Simparica™) against fleas on dogs presented as veterinary patients in the United States.
Cherni JA; Mahabir SP; Six RH
Vet Parasitol; 2016 May; 222():43-8. PubMed ID: 26947964
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of a combination of selamectin plus sarolaner for the treatment and prevention of flea infestations and the treatment of ear mites in cats presented as veterinary patients in the United States.
Vatta AF; Myers MR; Rugg JJ; Chapin S; Pullins A; King VL; Rugg D
Vet Parasitol; 2019 Jun; 270 Suppl 1():S3-S11. PubMed ID: 30579753
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of a new spot-on formulation of selamectin plus sarolaner in the treatment of naturally occurring flea and tick infestations in cats presented as veterinary patients in Europe.
Geurden T; Becskei C; Farkas R; Lin D; Rugg D
Vet Parasitol; 2017 Apr; 238 Suppl 1():S12-S17. PubMed ID: 28395750
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of imidacloprid 10% plus moxidectin 2.5% spot-on in the treatment of sarcoptic mange and otoacariosis in dogs: results af a European field study.
Krieger K; Heine J; Dumont P; Hellmann K
Parasitol Res; 2005 Oct; 97 Suppl 1():S81-S88. PubMed ID: 16228280
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of sarolaner in the treatment of canine ear mite infestation caused by Otodectes cynotis: a non-inferiority study.
Becskei C; Cuppens O; Mahabir SP
Vet Dermatol; 2018 Apr; 29(2):100-e39. PubMed ID: 29392787
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a novel oral formulation of sarolaner (Simparica™) against four common tick species infesting dogs in Europe.
Geurden T; Becskei C; Grace S; Strube C; Doherty P; Liebenberg J; Mahabir SP; Slootmans N; Lloyd A; Six RH
Vet Parasitol; 2016 May; 222():33-6. PubMed ID: 27068640
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the speed of kill, effects on reproduction, and effectiveness in a simulated infested-home environment of sarolaner (Simparica™) against fleas on dogs.
Six RH; Becskei C; Carter L; Gale B; Young DR; Mahabir SP; Chapin S; Myers MR
Vet Parasitol; 2016 May; 222():23-7. PubMed ID: 26961589
[TBL] [Abstract][Full Text] [Related]
16. Comparative speed of kill after treatment with Simparica™ (sarolaner) and Advantix®(imidacloprid + permethrin) against induced infestations of Dermacentor reticulatus on dogs.
Becskei C; Geurden T; Erasmus H; Cuppens O; Mahabir SP; Six RH
Parasit Vectors; 2016 Feb; 9():104. PubMed ID: 26911323
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of an imidacloprid/moxidectin combination against naturally acquired Sarcoptes scabiei infestations on dogs.
Fourie LJ; Heine J; Horak IG
Aust Vet J; 2006; 84(1-2):17-21. PubMed ID: 16498829
[TBL] [Abstract][Full Text] [Related]
18. Determination of the effective dose of a novel oral formulation of sarolaner (Simparica™) for the treatment and month-long control of fleas and ticks on dogs.
McTier TL; Six RH; Fourie JJ; Pullins A; Hedges L; Mahabir SP; Myers MR
Vet Parasitol; 2016 May; 222():12-7. PubMed ID: 26948830
[TBL] [Abstract][Full Text] [Related]
19. Treatment of canine sarcoptic mange with afoxolaner (NexGard
Hampel V; Knaus M; Schäfer J; Beugnet F; Rehbein S
Parasite; 2018; 25():63. PubMed ID: 30516132
[TBL] [Abstract][Full Text] [Related]
20. Comparative speed of kill of sarolaner (Simparica™ Chewables) and fluralaner (Bravecto(®)) against induced infestations of Amblyomma americanum on dogs.
Six RH; Young DR; Myers MR; Mahabir SP
Parasit Vectors; 2016 Jul; 9(1):399. PubMed ID: 27430425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
